{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T12:16:36Z","timestamp":1783426596106,"version":"3.54.6"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.msard.2026.107318","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T15:51:45Z","timestamp":1781020305000},"page":"107318","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Initial treatment choice for multiple sclerosis and prognosis at year 3 are associated with few poor prognosis factors"],"prefix":"10.1016","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1401-3921","authenticated-orcid":false,"given":"Mickael","family":"Bonnan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kit Yi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abir","family":"Wahab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mickael","family":"Zedet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Grimaldos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Lafont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Creange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2026.107318_bib0001","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/jon.12688","article-title":"Brain MRI predicts worsening multiple sclerosis disability over 5 years in the SUMMIT study","volume":"30","author":"Bakshi","year":"2020","journal-title":"J. Neuroimag."},{"key":"10.1016\/j.msard.2026.107318_bib0002","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jns.2016.11.067","article-title":"Prevalence of depression and anxiety in multiple sclerosis: a systematic review and meta-analysis","volume":"372","author":"Boeschoten","year":"2017","journal-title":"J. Neurol., Sci."},{"key":"10.1016\/j.msard.2026.107318_bib0003","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1136\/jnnp.55.8.671","article-title":"EDMUS, a European database for multiple sclerosis","volume":"55","author":"Confavreux","year":"1992","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2026.107318_bib0004","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/1352458516650512","article-title":"Influence of hypertension, diabetes, hyperlipidemia, and obstructive lung disease on multiple sclerosis disease course","volume":"23","author":"Conway","year":"2017","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2026.107318_bib0005","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1007\/s00415-019-09589-2","article-title":"Early MRI predictors of prognosis in multiple sclerosis","volume":"266","author":"Davda","year":"2019","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2026.107318_bib0006","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1136\/jnnp-2023-333307","article-title":"Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study","volume":"95","author":"Dekeyser","year":"2024","journal-title":"J. Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.msard.2026.107318_bib0007","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1177\/1352458517736147","article-title":"Asymptomatic spinal cord lesions do not predict the time to disability in patients with early multiple sclerosis","volume":"24","author":"Dekker","year":"2018","journal-title":"Mult. Scler"},{"key":"10.1016\/j.msard.2026.107318_bib0008","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1155\/2013\/484959","article-title":"Clinical, MRI, and CSF markers of disability progression in multiple sclerosis","volume":"35","author":"Gajofatto","year":"2013","journal-title":"Dis. Marker."},{"key":"10.1016\/j.msard.2026.107318_bib0009","article-title":"Relapse rate and MRI activity in young adult patients with multiple sclerosis: a post hoc analysis of phase 3 fingolimod trials","volume":"4","author":"G\u00e4rtner","year":"2018","journal-title":"Mult. Scler J. Exp. Transl. Clin."},{"key":"10.1016\/j.msard.2026.107318_bib0010","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1001\/jamaneurol.2015.1241","article-title":"Association of cortical lesion burden on 7-T magnetic resonance imaging with cognition and disability in Multiple sclerosis","volume":"72","author":"Harrison","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.msard.2026.107318_bib0011","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S1474-4422(20)30067-3","article-title":"Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study","volume":"19","author":"He","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2026.107318_bib0012","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1136\/jnnp.2008.150896","article-title":"CSF oligoclonal band status informs prognosis in multiple sclerosis: a case control study of 100 patients","volume":"80","author":"Joseph","year":"2009","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2026.107318_bib0013","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S0140-6736(98)03053-0","article-title":"Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis","volume":"353","author":"Kappos","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.msard.2026.107318_bib0014","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2014-310051","article-title":"Cardiovascular risk factors are associated with increased lesion burden and brain atrophy in multiple sclerosis","author":"Kappus","year":"2015","journal-title":"J. Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.msard.2026.107318_bib0015","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000584","article-title":"Does CSF pleocytosis have a predictive value for disease course in MS?","volume":"6","author":"Lotan","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"10.1016\/j.msard.2026.107318_bib0016","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S1474-4422(10)70135-6","article-title":"Emerging effects of comorbidities on multiple sclerosis","volume":"9","author":"Marrie","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2026.107318_bib0017","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1136\/jnnp.2007.124123","article-title":"Predicting short-term disability progression in early multiple sclerosis: added value of MRI parameters","volume":"79","author":"Minneboo","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2026.107318_bib0018","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s11910-020-01045-3","article-title":"Cognitive dysfunction in the early stages of multiple sclerosis\u2014how much and how important?","volume":"20","author":"Oset","year":"2020","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.msard.2026.107318_bib0019","series-title":"Multiple Sclerosis","article-title":"Diagnosis of multiple sclerosis","author":"Paty","year":"1998"},{"key":"10.1016\/j.msard.2026.107318_bib0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122686","article-title":"Male sex is independently associated with faster disability accumulation in relapse-onset MS but not in primary progressive MS","volume":"10","author":"Ribbons","year":"2015","journal-title":"PLoS One."},{"key":"10.1016\/j.msard.2026.107318_bib0021","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1212\/01.WNL.0000081305.66687.D2","article-title":"Smoking is a risk factor for multiple sclerosis","volume":"61","author":"Riise","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2026.107318_bib0022","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1212\/WNL.0b013e318230a17d","article-title":"Age and disability accumulation in multiple sclerosis","volume":"77","author":"Scalfari","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2026.107318_bib0023","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/WCO.0000000000000701","article-title":"Age and the risks of high-efficacy disease modifying drugs in multiple sclerosis","volume":"32","author":"Schweitzer","year":"2019","journal-title":"Curr., Opin, Neurol."},{"key":"10.1016\/j.msard.2026.107318_bib0024","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1177\/1352458508093615","article-title":"Smoking worsens the prognosis in multiple sclerosis","volume":"14","author":"Sundstr\u00f6m","year":"2008","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2026.107318_bib0025","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jns.2014.10.020","article-title":"Vascular comorbidities in the onset and progression of multiple sclerosis","volume":"347","author":"Tettey","year":"2014","journal-title":"J. Neurol, Sci."},{"key":"10.1016\/j.msard.2026.107318_bib0026","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1136\/jnnp.2008.145805","article-title":"& the UBCMS clinic neurologists*. Relapses in multiple sclerosis are age- and time-dependent","volume":"79","author":"Tremlett","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2026.107318_bib0027","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1212\/WNL.47.6.1469","article-title":"Accumulation of hypointense lesions (\u2018black holes\u2019) on T1 spin-echo MRI correlates with disease progression in multiple sclerosis","volume":"47","author":"Truyen","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2026.107318_bib0028","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3389\/fneur.2017.00577","article-title":"Meta-analysis of the age-dependent efficacy of Multiple sclerosis treatments","volume":"8","author":"Weideman","year":"2017","journal-title":"Front. Neurol"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826003548?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826003548?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T11:33:55Z","timestamp":1783424035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034826003548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":28,"alternative-id":["S2211034826003548"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2026.107318","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Initial treatment choice for multiple sclerosis and prognosis at year 3 are associated with few poor prognosis factors","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2026.107318","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107318"}}